Hu, Tianyan
Song, Yan
Done, Nicolae
Mohanty, Salini
Liu, Qing
Sarpong, Eric M.
Lemus-Wirtz, Esteban
Signorovitch, James
Weiss, Thomas
Funding for this research was provided by:
Merck Sharp & Dohme LLC
Article History
Received: 27 May 2022
Accepted: 6 March 2023
First Online: 25 April 2023
Declarations
:
: This study involved de-identified, aggregate data from a pre-existing dataset that was licensed to Merck & Co., Inc., Rahway, NJ, USA, and was not subject to Institutional Review Board approval at Merck & Co., Inc., Rahway, NJ, USA or Analysis Group, Inc. Informed consent was not needed as all patients were anonymized and only aggregate data are reported here. A research review committee at Merck & Co., Inc., Rahway, NJ, USA. approved the study protocol prior to the study initiation. All methods were performed in accordance with the relevant guidelines and regulations, including the principles of the Declaration of Helsinki.
: Not applicable.
: SM, ES, and TW are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and may own stock/stock options in Merck & Co., Inc., Rahway, NJ, USA. TH was an employee of Merck Sharp & Dohme LLC at the time the study was conducted.YS, ND, QL, ELW, and JS are employees of Analysis Group, Inc., a consulting firm that received funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA to conduct this study.